Skip to main content

Want a detailed portfolio tracker?

Codexis (CDXS) P/E (2013 - 2026)

Codexis (CDXS) P/E from Dec 31, 2013 to Jun 3, 2026. The TTM Codexis (CDXS) P/E is -7.69. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Codexis (CDXS)

YearP/EChange
2026-7.69+139.51%
2025-3.21-41.85%
2024-5.52+116.35%
2023-2.55-73.88%
2022-9.77-89.74%
2021-95.18+74.69%
2020-54.49-27.94%
2019-75.61-4.48%
2018-79.16+513.69%
2017-12.90-62.89%
2016-34.76+55.85%
2015-22.30+333.22%
2014-5.15-5.95%
2013-5.47N/A

Comparison Codexis (CDXS) P/E with competitors

Codexis (CDXS) P/E is -7.69.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.10-101.33%
ENLVEnlivex Therapeutics Ltd0.15-101.95%
FGENFibroGen Inc0.24-103.12%
TRAWTraws Pharma Inc0.47-106.15%
FBIOFortress Biotech Inc0.71-109.18%
CHRSCoherus Biosciences Inc0.98-112.72%
ORMPOramed Pharmaceuticals Inc1.47-119.17%
AGENAgenus Inc2.05-126.65%
VIVSVivoSim Labs Inc2.54-132.99%
INVAInnoviva Inc3.19-141.48%
CRMDCorMedix Inc3.65-147.43%
ABEOAbeona Therapeutics Inc4.20-154.70%
VXRTVaxart Inc4.26-155.44%
CVACCureVac N.V.4.45-157.83%
SRPTSarepta Therapeutics Inc4.62-160.16%
GLPGGalapagos NV4.86-163.21%
RIGLRigel Pharmaceuticals4.92-164.00%
ZVRAZevra Therapeutics Inc4.97-164.71%
ABUSArbutus Biopharma Corp5.69-174.07%
CGENCompugen Ltd7.38-196.06%
AUPHAurinia Pharmaceuticals Inc9.25-220.35%
ACADAcadia Pharmaceuticals Inc9.59-224.73%
OMEROmeros Corporation9.88-228.57%
PLXProtalix BioTherapeutics Inc9.91-228.91%
SPROSpero Therapeutics Inc10.73-239.65%
ADMAAdma Biologics Inc11.33-247.40%
SVASinovac Biotech Ltd11.44-248.77%
TBPHTheravance Biopharma Inc11.78-253.20%
HRMYHarmony Biosciences Holdings Inc12.18-258.46%
TGTXTG Therapeutics Inc13.18-271.45%
INCYIncyte Corp13.38-274.09%
SABSSAB Biotherapeutics Inc14.06-282.88%
XOMAXOMA Corp14.95-294.43%
REGNRegeneron Pharmaceuticals Inc14.98-294.88%
PBYIPuma Biotechnology Inc15.05-295.79%
EXELExelixis Inc15.79-305.48%
NAGENiagen Bioscience Inc16.35-312.76%
CPRXCatalyst Pharmaceuticals Inc17.34-325.64%
MDXGMimedx Group Inc17.38-326.04%
ARGXArgen X SE23.07-400.14%
HALOHalozyme Therapeutics Inc23.20-401.82%
XOMAOXOMA Corp25.34-429.72%
VRTXVertex Pharmaceuticals Inc25.66-433.76%
XOMAPXOMA Corp25.67-433.95%
CTMXCytomX Therapeutics Inc25.70-434.31%
ASNDAscendis Pharma A/S26.35-442.85%
RPRXRoyalty Pharma plc - Class A27.50-457.69%
SLNOSoleno Therapeutics Inc29.02-477.47%
LGNDLigand Pharmaceuticals Inc - Class B30.19-492.70%
BMRNBiomarin Pharmaceutical Inc37.51-587.94%
APLSApellis Pharmaceuticals Inc39.02-607.63%
KRYSKrystal Biotech Inc39.70-616.43%
GMABGenmab40.20-623.02%
ONCBeiGene Ltd67.03-971.97%
TECHBio-Techne Corp68.59-992.37%
VCELVericel Corp80.63-1148.92%
PHARPharming Group N.V.87.74-1241.43%
ALNYAlnylam Pharmaceuticals Inc124.93-1725.29%
TLXTelix Pharmaceuticals Ltd139.89-1919.87%
CORTCorcept Therapeutics Inc158.39-2160.52%